박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks

Daewoong Pharmaceutical’s ‘Ursa’ Shows Symptom Improvement in Early Post-COVID Patients

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

LigaChemBio Receives Milestone from Czech Sotio Biotech

Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"

Previous1112131415Next